Calgary, Alberta--(Newsfile Corp. - February 20, 2023) - Canada-based biotechnology company BioAro announces the unveiling of its new targeted cardiac panel for patients who face the potential risks ...

GAITHERSBURG, Md. — A Food and Drug Administration advisory panel voted 9-4 not to recommend approval of the CorCap Cardiac Support Device for patients with heart failure. Advisory panel votes are not ...

Nearly 8,000 cardiac panel blood tests have been recalled after 41 reports of inaccurate test results that pose the risk of missing a heart attack diagnosis, the FDA said July 17. Quidel ...

Chest pain is the second leading cause of admittance to Emergency Departments in the US. An early and accurate diagnosis of chest pain complaints is key to achieving improved patient outcomes through ...

Medtronic CRT-D Devices Demonstrate Survival Benefits for Mildly Symptomatic Heart Failure Patients in Two Pivotal Clinical Trials MINNEAPOLIS – Medtronic, Inc. today announced that the U.S. Food and ...

Please provide your email address to receive an email when new articles are posted on . The FDA’s Circulatory System Devices Panel recommended that an implantable cardiac monitor that alerts patients ...

For nearly two decades, some of the most renowned Florida doctors in heart-related medicine for children reviewed hospital pediatric cardiac surgery programs. But after issuing a critical report on St ...

Call for early screening stems from increasing evidence that cardiovascular problems are surfacing earlier in life, driven by sedentary habits, unhealthy diets, stress among teens In a push to tackle ...

On Tuesday, the Food and Drug Administration will convene a panel of experts -- again -- to discuss GlaxoSmithKline's (GSK) type II diabetes drug Avandia. Sales of Avandia, which topped $2.6 billion ...

(MENAFN- Newsfile Corp) BioAro Unveils Its Targeted Cardiac Panel for Patients Facing the Risk of Heart Failure During the Peak of Heart Month Calgary, Alberta--(Newsfile Corp. - February 20, 2023) - ...